A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

NCT05970432 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: TQH2722 injection 300mg-150mg
DRUG: TQH2722 injection 600mg-300mg
DRUG: TQH2722 injection 900mg-450mg
DRUG: TQH2722 injection matching Placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.